Skip to content

A study to compare oral pregabalin and intravenous dexmedetomidine in decreasing blood pressure and heart rate after laryngoscopy and intubation.

Comparison of oral pregabalin and intravenous dexmedetomidine in attenuating hemodynamic response to laryngoscopy and intubation : A randomized controlled study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096337
Enrollment
60
Registered
2025-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z00-Z99- Factors influencing health status and contact with health services Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: oral pregabalin: Group P patients will receive oral pregabalin 150 mg 1 hour prior to surgery.Patients will be preoxygenatated and standard anaesthesia protocol will be followed after t

Sponsors

SHUBHADA BHAGAT
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 scheduled for elective surgery under general anaesthesia requiring orotracheal intubation

Exclusion criteria

Exclusion criteria: Following patients will be excluded from the study 1 Refusal to consent 2 Anticipated difficult airway 3 Patients whose intubation procedure will last more than 15 seconds. 4 Patients with known allergy to study drugs 5 Patients requiring more than 1 intubation attempt 6 Neurosurgery patients 7 Cervical spine instability 8 Patients having history of cardiac or liver disease 9 Patients having baseline heart rate less than 50 in min or having AV blocks 10 Morbid obesity 11 Pregnant and lactating females

Design outcomes

Primary

MeasureTime frame
To determine whether a statistically significant reduction in hemodynamic response to laryngoscopy and intubation occurs with 150 mg oral pregabalin as compared to 1 mcg/kg of iv dexmedetomidine.Timepoint: HR, SBP, MAP, DBP at 1 min, 3 min, 5 min and 10 min post intubation

Secondary

MeasureTime frame
Side effects like bradycardia, hypotension in intraoperative and postoperative period. Sedation, nausea, vomiting will be noted in postoperative period. Timepoint: Intraoperative and postoperative period for 2 hours

Countries

India

Contacts

Public ContactSHUBHADA BHAGAT

PGIMS, ROHTAK, HARYANA

shubhadabhagat56@gmail.com9540927325

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026